Antibodies News and Research

RSS
Calcitonin-gene related peptide antibody inhibition shows migraine prevention promise

Calcitonin-gene related peptide antibody inhibition shows migraine prevention promise

Predicting better immunotherapy response, neurological outcomes in adults with autoimmune cerebellar ataxia

Predicting better immunotherapy response, neurological outcomes in adults with autoimmune cerebellar ataxia

New research identifies genetic variants, causal links associated with polycystic ovary syndrome

New research identifies genetic variants, causal links associated with polycystic ovary syndrome

Serologic status and autoimmune cerebellar ataxia type predict treatment response

Serologic status and autoimmune cerebellar ataxia type predict treatment response

Study: Biomarkers in maternal blood may predict risk for adverse outcomes in pregnant women with SLE

Study: Biomarkers in maternal blood may predict risk for adverse outcomes in pregnant women with SLE

Unique molecule can bind HIV-infected cells to killer T cells

Unique molecule can bind HIV-infected cells to killer T cells

Scientists develop new molecular toolkit to investigate protein assemblies in human disease

Scientists develop new molecular toolkit to investigate protein assemblies in human disease

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Atezolizumab may change treatment strategies for refractory lung cancer patients

Atezolizumab may change treatment strategies for refractory lung cancer patients

Annual flu vaccine may offer protection regardless of any viral strain, says Penn State physician

Annual flu vaccine may offer protection regardless of any viral strain, says Penn State physician

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

Researchers develop new blood test to diagnose coeliac disease

Researchers develop new blood test to diagnose coeliac disease

DNA nanostructures provide novel applications in molecular medicine

DNA nanostructures provide novel applications in molecular medicine

Researchers reveal potential new treatment methods for fatal brain disease

Researchers reveal potential new treatment methods for fatal brain disease

Cattle virus found in human cancer cells

Cattle virus found in human cancer cells

Researchers establish link between bovine leukemia virus and human breast cancer

Researchers establish link between bovine leukemia virus and human breast cancer

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

EORTC trial evaluates effectiveness of pembrolizumab in patients with high-risk stage III melanoma

EORTC trial evaluates effectiveness of pembrolizumab in patients with high-risk stage III melanoma

Combining epigenetic drugs with immunotherapies may provide additional clinical benefit to cancer patients

Combining epigenetic drugs with immunotherapies may provide additional clinical benefit to cancer patients

Caltech researchers find antibody that can detect, neutralize HIV viruses in infected patients

Caltech researchers find antibody that can detect, neutralize HIV viruses in infected patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.